RxStrategies, Inc., Boca Raton, FL. A comprehensive self-audit solution to streamline workflow, quickly indemnify errors and omissions and implement processes to ensure 340B program compliance.The right contract pharmacy solution to fit your organization’s specific needs.Allows for expansion of your contract pharmacy network to include specialty drugs that would go un-captured in a traditional retail contract pharmacy network.Standardizes your 340B business relationships on one platform to maximize compliance, visibility, operational efficiency, capture rate, inventory reconciliation and replenishment.
The Registered Agent on file for this company is Myra Marcelo and is located at 3960 Adeline St Ste 303, Emeryville, CA 94608.
You can’t afford to spend time on research or analysis that doesn’t make the final cut. The Registered Agent on file for this company is Corporation Service Company and is located at 7716 Old Canton Rd, suite C, Madison, MS 39110.
New Drug Approval OlinvykTM (oliceridine) Injection – New Drug Approval – August 7, 2020 – The U.S. Food and Drug Administration approved OlinvykTM (oliceridine), an opioid agonist for the management ofRxStrategies is grateful for the support and quality care provided by Community Health Centers across the U.S., and we are honored to support their efforts. "The exemplary customer service RxStrategies' sales department and account managers provide is a key component of our strong partnership." The RxStrategies team was there for us at a moment’s notice." Addresses the complexity out of 340B program management by reviewing all prescription activity to flag eligible 340B dispenses.
RxStrategies provides turn-key solutions for the 340B discount prescription drug program (USA). Energy Strategy Reviews authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work. Fenton has served as President and Chief Executive Officer of RxStrategies, Inc since 2005. With more than 30 years of experience as a Chief Financial Officer and Chief Executive Officer of technology based organizations, Markevich brings a disciplined approach to addressing the complex issues of managing and administering the complexities of the 340B program. Delivery Driver (11) Driver (9) Independent Contractor (9) Courier (8) Contractor (5) See more SDS-Rx reviews by job title. Energy Strategy Reviews continues with the same aims and scope, editorial team, submission system and rigorous peer review. "Due to RxStrategies' comprehensive solutions specifically for FQHCs to manage a compliant 340B program, our available discounts from the 340B program tripled in the rural areas where we operate in partnership with contract pharmacies. RxStrategies, Inc - We offer a range of services for hospitals including evaluation of patient mix, staff and medical training and OPA registration and compliance review. McKinsey’s Decision Tree or Bain’s Answer First approaches). Rx Strategies, Inc. is a Mississippi Profit Corporation filed on April 24, 2019.
Every day needs to count. ""Communication throughout the transition process from another TPA was stellar. © 2020 RxStrategies, Inc. All Rights Reserved.
""Communication throughout the transition process from another TPA was stellar. Rochester, NY (6) Cinnaminson, NJ (5) Edison, NJ (4) Syracuse, NY (4) Winston-Salem, NC (4) See more SDS-Rx reviews by location . "The exemplary customer service RxStrategies' sales department and account managers provide is a key component of our strong partnership." What would you add or change?
13 likes. The company's filing status is listed as Canceled and its File Number is 200628610088.
Rx Strategies LLC is a California Domestic Limited-Liability Company filed on October 11, 2006.
RxStrategies, Inc - We offer a range of services for hospitals including evaluation of patient mix, staff and medical training and OPA registration and compliance review. Provides fully customizable, end-to-end 340B program management with a focus on program compliance.A comprehensive self-audit solution to streamline workflow, quickly identify errors and omissions and implement processes to ensure 340B program compliance.Our network helps to ensure 340B eligible patient compliance and access to competitively priced prescriptions.Integrated solutions that assist providers in meeting the challenges of maintaining a compliant 340B Drug Pricing Program.Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. The company's filing status is listed as Good Standing and its File Number is 1176223. Strategic reviews are often undertaken under considerable pressure to get to an answer rapidly. To design and implement customized 340B pharmacy solutions that allow our clients to maximize the value of the Federal 340B discount drug pricing program within and across their organization. The leading strategy firms, therefore, adopt a hypothesis-led approach to strategy formulation (e.g.